Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging

  • Vania Kenanova
  • Bhaswati Barat
  • Tove Olafsen
  • Arion Chatziioannou
  • Harvey R. Herschman
  • Jonathan Braun
  • Anna M. Wu
Original Article

Abstract

Purpose

Reporter genes can provide a way of noninvasively assessing gene activity in vivo. However, current reporter gene strategies may be limited by the immunogenicity of foreign reporter proteins, endogenous expression, or unwanted biological activity. We have developed a reporter gene based on carcinoembryonic antigen (CEA), a human protein with limited normal tissue expression.

Methods

To construct a CEA reporter gene for PET, a CEA minigene (N-A3) was fused to the extracellular and transmembrane domains of the human FcγRIIb receptor. The NA3-FcγRIIb recombinant gene, driven by a CMV promoter, was transfected in Jurkat (human T cell leukemia) cells. Expression was analyzed by flow cytometry, immunohistochemistry (IHC), and microPET imaging.

Results

Flow cytometry identified Jurkat clones stably expressing NA3-FcγRIIb at low, medium, and high levels. High and medium NA3-FcγRIIb expression could also be detected by Western blot. Reporter gene positive and negative Jurkat cells were used to establish xenografts in athymic mice. IHC showed staining of the tumor with high reporter gene expression; medium and low N-A3 expression was not detected. MicroPET imaging, using an anti-CEA 124I-labeled single-chain Fv-Fc antibody fragment, demonstrated that only high N-A3 expression could be detected. Specific accumulation of activity was visualized at the N-A3 positive tumor as early as 4 h. MicroPET image quantitation showed tumor activity of 1.8 ± 0.2, 15.2 ± 1.3, and 4.6 ± 1.2 percent injected dose per gram (%ID/g) at 4, 20, and 48 h, respectively. Biodistribution at 48 h demonstrated tumor uptake of 4.8 ± 0.8%ID/g.

Conclusion

The CEA N-A3 minigene has the potential to be used as a reporter gene for imaging cells in vivo.

Keywords

T cells CEA reporter gene Jurkat xenograft 124I-labeled scFv-Fc antibody fragment MicroPET/microCT imaging 

References

  1. 1.
    Alam J, Cook JL. Reporter genes: application to the study of mammalian gene transcription. Anal Biochem 1990;188(2):245–54.PubMedCrossRefGoogle Scholar
  2. 2.
    Serganova I, Blasberg R. Reporter gene imaging: potential impact on therapy. Nucl Med Biol 2005;32(7):763–80.PubMedCrossRefGoogle Scholar
  3. 3.
    Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 2002;43(8):1072–83.PubMedGoogle Scholar
  4. 4.
    MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, et al. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 1999;6(5):785–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Ur E, Bomanji J, Mather SJ, Britton KE, Wass JA, Grossman AB, et al. Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide. Clin Endocrinol (Oxf) 1993;38(5):501–6.CrossRefGoogle Scholar
  6. 6.
    Haberkorn U, Henze M, Altmann A, Jiang S, Morr I, Mahmut M, et al. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 2001;42(2):317–25.PubMedGoogle Scholar
  7. 7.
    Altmann A, Kissel M, Zitzmann S, Kubler W, Mahmut M, Peschke P, et al. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma. J Nucl Med 2003;44(6):973–80.PubMedGoogle Scholar
  8. 8.
    Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997;276(5319):1719–24.PubMedCrossRefGoogle Scholar
  9. 9.
    Verzeletti S, Bonini C, Marktel S, Nobili N, Ciceri F, Traversari C, et al. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum Gene Ther 1998;9(15):2243–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Liang Q, Satyamurthy N, Barrio JR, Toyokuni T, Phelps MP, Gambhir SS, et al. Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 2001;8(19):1490–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Ajjan RA, Kamaruddin NA, Crisp M, Watson PF, Ludgate M, Weetman AP. Regulation and tissue distribution of the human sodium iodide symporter gene. Clin Endocrinol (Oxf) 1998;49(4):517–23.CrossRefGoogle Scholar
  12. 12.
    Smanik PA, Ryu KY, Theil KS, Mazzaferri EL, Jhiang SM. Expression, exon–intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 1997;138(8):3555–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Spitzweg C, Joba W, Eisenmenger W, Heufelder AE. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 1998;83(5):1746–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Serganova I, Ponomarev V, Blasberg R. Human reporter genes: potential use in clinical studies. Nucl Med Biol 2007;34(7):791–807.PubMedCrossRefGoogle Scholar
  15. 15.
    Dubey P, Su H, Adonai N, Du S, Rosato A, Braun J, et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci U S A 2003;100(3):1232–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 2003;21(4):405–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57(2):327–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Shively JE, Beatty JD. CEA-related antigens: molecular biology and clinical significance. Crit Rev Oncol Hematol 1985;2(4):355–99.PubMedCrossRefGoogle Scholar
  19. 19.
    Toth CA, Thomas P, Broitman SA, Zamcheck N. Receptor-mediated endocytosis of carcinoembryonic antigen by rat liver Kupffer cells. Cancer Res 1985;45(1):392–7.PubMedGoogle Scholar
  20. 20.
    Raben D, Buchsbaum DJ, Khazaeli MB, Rosenfeld ME, Gillespie GY, Grizzle WE, et al. Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene. Gene Ther 1996;3(7):567–80.PubMedGoogle Scholar
  21. 21.
    Kenanova V, Olafsen T, Crow DM, Sundaresan G, Subbarayan M, Carter NH, et al. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res 2005;65(2):622–31.PubMedGoogle Scholar
  22. 22.
    You YH, Hefta LJ, Yazaki PJ, Wu AM, Shively JE. Expression, purification, and characterization of a two domain carcinoembryonic antigen minigene (N-A3) in Pichia pastoris. The essential role of the N-domain. Anticancer Res 1998;18(5A):3193–201.PubMedGoogle Scholar
  23. 23.
    Schrewe H, Thompson J, Bona M, Hefta LJ, Maruya A, Hassauer M, et al. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression. Mol Cell Biol 1990;10(6):2738–48.PubMedGoogle Scholar
  24. 24.
    Brooks DG, Qiu WQ, Luster AD, Ravetch JV. Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J Exp Med 1989;170(4):1369–85.PubMedCrossRefGoogle Scholar
  25. 25.
    Olafsen T, Kenanova VE, Wu AM. Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment. Nat Protoc 2006;1(4):2048–60.PubMedCrossRefGoogle Scholar
  26. 26.
    Neumaier M, Shively L, Chen FS, Gaida FJ, Ilgen C, Paxton RJ, et al. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. Cancer Res 1990;50(7):2128–34.PubMedGoogle Scholar
  27. 27.
    Neville DM Jr., Scharff J, Srinivasachar K. In vivo T-cell ablation by a holo-immunotoxin directed at human CD3. Proc Natl Acad Sci U S A 1992;89(7):2585–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Defrise M, Kinahan PE, Townsend DW, Michel C, Sibomana M, Newport DF. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imaging 1997;16(2):145–58.PubMedCrossRefGoogle Scholar
  29. 29.
    Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003;2(3):131–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001;19:275–90.PubMedCrossRefGoogle Scholar
  31. 31.
    Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991;5(5):344–66.PubMedCrossRefGoogle Scholar
  32. 32.
    Berk DA, Yuan F, Leunig M, Jain RK. Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc Natl Acad Sci U S A 1997;94(5):1785–90.PubMedCrossRefGoogle Scholar
  33. 33.
    Kenanova V, Olafsen T, Williams LE, Ruel NH, Longmate J, Yazaki PJ, et al. Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy. Cancer Res 2007;67(2):718–26.PubMedCrossRefGoogle Scholar
  34. 34.
    Zalutsky MR, Noska MA, Colapinto EV, Garg PK, Bigner DD. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate. Cancer Res 1989;49(20):5543–9.PubMedGoogle Scholar
  35. 35.
    Geissler F, Anderson SK, Venkatesan P, Press O. Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells. Cancer Res 1992;52(10):2907–15.PubMedGoogle Scholar
  36. 36.
    Yaghoubi S, Barrio JR, Dahlbom M, Iyer M, Namavari M, Satyamurthy N, et al. Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med 2001;42(8):1225–34.PubMedGoogle Scholar
  37. 37.
    Voges J, Reszka R, Gossmann A, Dittmar C, Richter R, Garlip G, et al. Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann Neurol 2003;54(4):479–87.PubMedCrossRefGoogle Scholar
  38. 38.
    Gangopadhyay A, Thomas P. Processing of carcinoembryonic antigen by Kupffer cells: recognition of a penta-peptide sequence. Arch Biochem Biophys 1996;334(1):151–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991;9:457–92.PubMedGoogle Scholar
  40. 40.
    Hulett MD, Witort E, Brinkworth RI, McKenzie IF, Hogarth PM. Identification of the IgG binding site of the human low affinity receptor for IgG Fc gamma RII. Enhancement and ablation of binding by site-directed mutagenesis. J Biol Chem 1994;269(21):15287–93.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Vania Kenanova
    • 1
  • Bhaswati Barat
    • 1
  • Tove Olafsen
    • 1
  • Arion Chatziioannou
    • 1
  • Harvey R. Herschman
    • 1
  • Jonathan Braun
    • 2
  • Anna M. Wu
    • 1
  1. 1.Crump Institute for Molecular Imaging, Department of Molecular and Medical PharmacologyDavid Geffen School of Medicine at the University of California Los AngelesLos AngelesUSA
  2. 2.Department of Pathology and Laboratory MedicineDavid Geffen School of Medicine at the University of California Los AngelesLos AngelesUSA

Personalised recommendations